While knee replacement surgery is generally considered safe and successful, like any surgical procedure, it carries potential complications. These can include:
Infection: Infection at the surgical site is a risk, typically occurring within the first few weeks or even years after surgery. Antibiotics are administered before and after surgery to minimize this risk.
Blood Clots: Formation of blood clots in the legs (deep vein thrombosis) or lungs (pulmonary embolism) is a concern. Medications, compression stockings, and early mobilization are employed to reduce this risk.
Implant Issues: Problems with the artificial joint may arise, such as loosening, dislocation, or wear and tear over time. These issues might necessitate additional surgery or revision.
Nerve or Blood Vessel Damage: Nearby nerves or blood vessels may sustain damage during surgery, leading to numbness, tingling, or circulation problems. These complications are uncommon but possible.
Persistent Pain or Stiffness: Some patients may experience persistent pain or stiffness, particularly if expectations regarding post-surgical mobility are not met.
Allergic Reactions: Though rare, patients may have allergic reactions to materials used in the implant. Thorough pre-operative assessments are conducted to minimize this risk.
Chronic Regional Pain Syndrome (CRPS): This rare but serious condition may cause prolonged pain, swelling, and changes in skin color around the knee.
Patients should be aware of these potential complications and engage in thorough discussions with their healthcare team to understand individualized risks, preventive measures, and post-operative care to minimize these risks. Regular follow-ups and adherence to rehabilitation protocols are essential in managing and preventing complications after knee replacement surgery.
Explore QC Kinetix (Liberty) for effective, over-the-counter solutions to ease muscle pain and promote comfort. Discover relief at QC Kinetix (Liberty).
Visit https://qckinetix.com/cincinnati/liberty-township-oh/ to know more.